Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

被引：0
|
作者：
Helen Y Chu
Rupali Jain
Hu Xie
Paul Pottinger
David N Fredricks
机构：
[1] University of Washington,Division of Allergy & Infectious Diseases, Department of Medicine
[2] University of Washington Medical Center,Department of Pharmacy
[3] Fred Hutchinson Cancer Research Center,Vaccine and Infectious Diseases Division
来源：
BMC Infectious Diseases | / 13卷
关键词：
Voriconazole; Therapeutic drug monitoring; Antifungals; Clinical efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The utility of voriconazole therapeutic drug monitoring in a multi-racial cohort in Southeast Asia
    Zhou, Peijun Yvonne
    Lim, Tze Peng
    Tang, Si Lin Sarah
    Liew, Yixin
    Chua, Sy Grace Nathalie
    Lim, Li Ling Cheryl
    Lee, Hui Ling Winnie
    Tan, Si Xuan
    Lai, Oi Fah
    Thuan Tong Tan
    Wong, Gee Chuan
    Kwa, Lay Hoon Andrea
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 : 427 - 433
  • [22] Therapeutic drug monitoring and genotypic screening in the clinical use of voriconazole
    Moriyama B.
    Kadri S.
    Henning S.A.
    Danner R.L.
    Walsh T.J.
    Penzak S.R.
    Current Fungal Infection Reports, 2015, 9 (2) : 74 - 87
  • [23] The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections
    Kang, Hyun Mi
    Lee, Hoan Jong
    Cho, Eun Young
    Yu, Kyung-Sang
    Lee, Hyunju
    Lee, Ji Won
    Kang, Hyoung Jin
    Park, Kyung Duk
    Shin, Hee Young
    Choi, Eun Hwa
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (08) : 557 - 567
  • [24] Therapeutic drug monitoring of voriconazole in sputum
    Wils, J.
    Imbert, L.
    Lambert, T.
    Sarfati, S.
    Mory, C.
    Pramil, S.
    Morisse-Pradier, H.
    Lamoureux, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 128 - 128
  • [25] Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
    Sarfati, Sacha
    Wils, Julien
    Lambert, Timothee
    Mory, Celine
    Imbert, Laurent
    Gargala, Gilles
    Morisse-Pradier, Helene
    Lamoureux, Fabien
    PHARMACEUTICS, 2022, 14 (08)
  • [26] Potential of Albumin-Bilirubin Score for Estimating the Voriconazole-Induced Hepatotoxicity Undergoing Therapeutic Drug Monitoring: A Single-Center Retrospective Cohort Study
    Asai, Yuki
    Kato, Hideo
    Tawara, Isao
    Nakano, Yuki
    Iwamoto, Takuya
    CLINICAL THERAPEUTICS, 2025, 47 (04) : 330 - 334
  • [27] Therapeutic drug monitoring and safety of voriconazole in elderly patients
    Cheng, Lin
    Xiang, Rongfeng
    Liu, Fang
    Li, Yuliang
    Chen, Heli
    Yao, Pu
    Sun, Fengjun
    Xia, Peiyuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 78
  • [28] IMPACT OF THERAPEUTIC DRUG MONITORING OF VORICONAZOLE IN A PEDIATRIC POPULATION
    Brueggemann, Roger J. M.
    van der Linden, Jan W. M.
    Verweij, Paul E.
    Burger, David M.
    Warris, Adilia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (06) : 533 - 534
  • [29] Therapeutic drug monitoring in voriconazole-associated hyponatremia
    Xu, Ren-ai
    Zheng, Shuang-li
    Xiao, Li-li
    Cai, Xue-ding
    Lai, Xi-xi
    Lin, Guan-yang
    Hu, Lu-feng
    Zhang, Chun-hong
    Xu, Zhi-sheng
    Zhang, Xiu-hua
    MEDICAL MYCOLOGY CASE REPORTS, 2013, 2 : 134 - 136
  • [30] Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care
    van Wanrooy, Marjolijn J. P.
    Rodgers, Michael G. G.
    Span, Lambert F. R.
    Zijlstra, Jan G.
    Uges, Donald R. A.
    Kosterink, Jos G. W.
    van der Werf, Tjip S.
    Alffenaar, Jan-Willem C.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 313 - 318
12345